IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...
Analysts fell to the sidelines weighing in on Teleflex (TFX – Research Report) and Revvity (RVTY – Research Report) with neutral ratings, ...
In honor of National CRNA Week (), U.S. House Representatives Jan Schakowsky (D-IL), Dave Joyce (R-OH), Suzanne Bonamici (D-OR), Brian Fitzpatrick (R-PA), Eleanor Holmes Norton (D-DC) and Paul Tonko ...
Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™
The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 billion in 2024 and an impressive US$5.93 billion by ...
The multiyear agreement calls for Chicago-based GE HealthCare provide AI-enabled diagnostic imaging technology to Nuffield ...
GE HealthCare is researching imaging tech for improved diagnosis and treatment of patients with cancer and neurodegenerative ...
In 2024, Wipro GE Healthcare — a joint venture between Wipro and GE Healthcare — announced an investment of $1 billion in manufacturing output and local R&D over the next five years.
SAN FRANCISCO—GE HealthCare struck a seven-year agreement with Sacramento, California-based Sutter Health to provide AI-powered medical imaging technology and digital solutions. The agreement ...
The last one, which is perhaps the most innovative of the recent ones, is the science and technology organisation focusing on AI. That is the core of AI for GE HealthCare. This horizontal works ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback